New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Epidural anesthesia and hypotension in pheochromocytoma and paraganglioma.
Epidural anesthesia and hypotension in pheochromocytoma and paraganglioma. Endocrine-related cancer Wiseman, D., McDonald, J. D., Patel, D., Kebebew, E., Pacak, K., Nilubol, N. 2020Abstract
Postoperative hypotension occurs frequently after resection of pheochromocytoma and/or paraganglioma (PPGLs). Epidural anesthesia (EA) is often used for pain control in open resection of these tumors; one of its side effects is hypotension. Our aim is to determine if EA is associated with an increased risk of postoperative hypotension after open resection of PPGLs. We conducted a retrospective review of patients who underwent open resection of PPGLs at the National Institutes of Health from 2004-2019. Clinical and perioperative parameters were analyzed by the use of EA. The primary endpoint was postoperative hypotension. Ninety-seven patients (46 female and 51 male; mean age, 38.5 years) underwent open resection of PPGLs, and 69 (71.1%) received EA. Patients with EA had a higher rate beta-blocker use (79.7% vs. 57.1%, P=0.041), metastasis (69.6% vs. 39.3%, P=0.011), and were more frequently hypotensive after surgery (58.8% vs. 25.0%, P=0.003) compared to those without EA. Patients with postoperative hypotension had higher plasma normetanephrines than those without (7.3-fold vs. 4.1-fold above the upper limit of normal, P=0.018). Independent factors associated with postoperative hypotension include the use of beta-blockers (HR = 3.35 [95% CI: 1.16-9.67], P=0.026) and EA (HR = 3.49 [95% CI: 1.25-9.76], P=0.017). Data from this retrospective study suggest that in patients with open resection of PPGLs, EA is an independent risk factor for early postoperative hypotension. Special caution is required in patients on betablockade. A prospective evaluation with standardized protocols for the use of EA and management of hemodynamic variability is necessary.
View details for DOI 10.1530/ERC-20-0139
View details for PubMedID 32698142